Snapshot from Jul 01, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Business / Regencell Bioscience Faces Multiple...
Business class action lawsuit

Regencell Bioscience Faces Multiple Class Actions

Analysis based on 132 articles · First reported Apr 25, 2026 · Last updated Jun 18, 2026

Sentiment
-70
Attention
4
Articles
132
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The ongoing class action lawsuits and the United States — United States Department of Justice investigation into Regencell Bioscience Holdings' trading activities are expected to continue to negatively impact the company's stock price and market valuation. Investors who purchased Regencell Bioscience Holdings securities during the Class Period face significant financial risk and potential losses, while the involved law firms aim to recover damages for affected shareholders.

biotechnology legal services
Event Summary

Regencell Bioscience Holdings is facing multiple class action lawsuits from law firms including Rosen Law Firm, Faruqi & Faruqi, Bronstein, Gewirtz & Grossman, LLC, and The Gross Law Firm. These lawsuits allege that Regencell Bioscience Holdings and its officers made materially false and misleading statements between October 28, 2024, and October 31, 2025, regarding the company's business, operations, and compliance policies. Specifically, the complaints claim that Regencell Bioscience Holdings was vulnerable to market manipulation, leading to significant volatility in its share price and exposing investors to financial risk. This situation has subjected Regencell Bioscience Holdings to a heightened risk of regulatory and governmental scrutiny, including an investigation by the United States — United States Department of Justice into the trading of its ordinary shares. The company's stock price fell significantly following the disclosure of the DOJ investigation. Investors are being encouraged to join these class actions, with a lead plaintiff deadline of June 23, 2026.

Key Actions
100 Bragar Eagel & Squire filed lawsuit Regencell Bioscience Holdings
95 Regencell Bioscience Holdings disclosed investigation United States — United States Department of Justice
95 Bronstein, Gewirtz & Grossman, LLC filed class action lawsuit Regencell Bioscience Holdings
95 Levi & Korsinsky filed class action lawsuit Regencell Bioscience Holdings
91 United States — United States Department of Justice conducted investigation into Regencell Bioscience Holdings
90 Rosen Law Firm announces class action lawsuit Regencell Bioscience Holdings
90 Regencell Bioscience Holdings fell in share price
81 The Law Offices of Frank R. Cruz filed class action lawsuit Regencell Bioscience Holdings
80 Faruqi & Faruqi investigated claims Regencell Bioscience Holdings
80 Glancy Prongay & Murray filed class action lawsuit Regencell Bioscience Holdings
80 Robbins LLP filed class action lawsuit Regencell Bioscience Holdings
80 Levi & Korsinsky examined adequacy of disclosures Regencell Bioscience Holdings
70 Bragar Eagel & Squire encouraged investors to contact
Entities Involved
stock
Regencell Bioscience Holdings
Regencell Bioscience Holdings is the target of multiple class action lawsuits and a Department of Justice investigation due to alleged market manipulation and misleading statements, which has caused its share price to fall and exposed it to significant financial, legal, and reputational harm.
Importance 100 Sentiment -75
govactor
United States — United States Department of Justice
The United States — United States Department of Justice is conducting an investigation into the trading of Regencell Bioscience Holdings' ordinary shares, indicating potential regulatory and enforcement action.
Importance 95 Sentiment 0
priv
Rosen Law Firm
Rosen Law Firm is actively representing investors in a class action lawsuit against Regencell Bioscience Holdings, seeking to recover damages for alleged securities fraud.
Importance 90 Sentiment 20
priv
Levi & Korsinsky
Levi & Korsinsky is the law firm that filed the class action lawsuit against Regencell Bioscience Holdings, representing aggrieved shareholders and seeking to recover losses.
Importance 90 Sentiment 70
priv
Faruqi & Faruqi
Faruqi & Faruqi is investigating potential claims against Regencell Bioscience Holdings and reminds investors of the deadline to seek lead plaintiff status in the federal securities class action.
Importance 85 Sentiment 20
priv
Bronstein, Gewirtz & Grossman, LLC
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Regencell Bioscience Holdings and its officers, alleging violations of federal securities laws.
Importance 80 Sentiment 20
per
Philip Kim
Philip Kim, an attorney at Rosen Law Firm, is a key contact for investors interested in joining the class action lawsuit against Regencell Bioscience Holdings.
Importance 70 Sentiment 20
per
Lawrence Rosen
Lawrence Rosen, founding partner of Rosen Law Firm, is highlighted for his firm's success in securities class actions and its role in the Regencell Bioscience Holdings lawsuit.
Importance 70 Sentiment 20
priv
Glancy Prongay & Murray
Glancy Prongay & Murray is one of the law firms representing investors in the securities fraud class action lawsuit against Regencell Bioscience Holdings.
Importance 70 Sentiment 20
per
Joseph E. Levi
Joseph E. Levi, Esq. is a key contact at Levi & Korsinsky, LLP, actively involved in notifying investors and leading the class action lawsuit against Regencell Bioscience Holdings.
Importance 70 Sentiment 60
priv
Robbins LLP
Robbins LLP is investigating allegations that Regencell Bioscience Holdings was impacted by a stock manipulation scheme and has filed a class action lawsuit on behalf of investors.
Importance 70 Sentiment 40
per
Peretz Bronstein
Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC, emphasizes the firm's commitment to restoring investor capital and ensuring corporate accountability in the Regencell Bioscience Holdings case.
Importance 60 Sentiment 20
priv
The Law Offices of Frank R. Cruz
The The Law Offices of Frank R. Cruz is also representing investors in the securities fraud class action lawsuit against Regencell Bioscience Holdings.
Importance 60 Sentiment 20
per
Josh Wilson
Josh Wilson is a Securities Litigation Partner at Faruqi & Faruqi who is encouraging investors to contact him regarding their losses in Regencell Bioscience Holdings.
Importance 60 Sentiment 50
per
Yat-Gai Au
Yat-Gai Au, as a major shareholder of Regencell Bioscience Holdings, is implicated in the lawsuit due to his significant ownership and alleged awareness of trading irregularities.
Importance 50 Sentiment -70
+ 7 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.